Está en la página 1de 2

JOWee 9

JAKARTA ONCOLOGY WEEKEND

CDK 4/6 Inhibitor: A New Avenue in


HR+, HER2– Advanced Breast Cancer
Sheraton Grand Gandaria City - Meeting Room 8 Lt. UG
Jakarta 7 September 2019

The Indonesian Society of INVITATION


Hematology Medical Oncology Registration:
(Jakarta Chapter) Fitri 089630808370
(WhatsApp only)
JOWee 9
The Indonesian Society of
Hematology Medical Oncology
JAKARTA ONCOLOGY WEEKEND (Jakarta Chapter)
CDK 4/6 Inhibitor: A New Avenue in
HR+, HER2– Advanced Breast Cancer
Sheraton Grand Gandaria City - Meeting Room 8 Lt. UG
Jakarta 7 September 2019

AGENDA

TIME DETAIL SPEAKER


08.00 – 09.00 Registration ALL

Welcome Speech Chairman of JOWee 9


09.00 – 09.15
Opening Remarks Head of Perhompedin Jaya

Moderator:
Dr. dr. Djumhana Atmakusuma, SpPD-KHOM

09.15 – 09.35 Rationale for Targeting CDK 4/6 in Breast Cancer Dr. dr. Cosphiadi Irawan, SpPD-KHOM, FINASIM

Clinical Evidences of CDK 4/6 Inhibitor in Postmenopausal


09.35 – 09.55 Dr. dr. Hilman Tadjoedin, SpPD-KHOM
HR+, HER2– Advanced Breast Cancer

Emerging Role of CDK 4/6 Inhibitor in Premenopausal


09.55 – 10.15 Dr. dr. Nugroho Prayogo, SpPD-KHOM, FINASIM
HR+, HER2– Advanced Breast Cancer
Understanding Safety Profile of CDK 4/6 Inhibitor to
10.15 – 10.35 dr. Nadia Ayu Mulansari, SpPD-KHOM, FINASIM
Optimize Patient Outcome

10.35 – 11.05 Discussion ALL

Closing Remarks Head of Perhompedin Jaya


11.05 – 11.15
Group Photo ALL
LUNCH & PRAYER

También podría gustarte